Financing type:  best efforts prospectus offering

Gross proceeds:  $5,750,276

Offering:  20,536,700 common shares with 20,536,700 warrants (including the gross proceeds from the full exercise of the overallotment option)

Offering price:  28 cents per common share

Warrant exercise terms:  40 cents per common share for a three-year period

Overallotment option:  The agents may purchase a maximum of 2,678,700 common shares and 2,678,700 warrants for overallotment purposes. As of Nov. 11, 2025, such option has been exercised in full. All information presented herein includes such exercise.

Commissions in securities:  1,172,202 warrants

Commission terms:   each non-transferable warrant is exercisable at 40 cents for a three-year period

Disclosure:  refer to the prospectus dated Nov. 29, 2024, the prospectus supplement dated Nov. 3, 2025, and company's news release(s) dated Oct. 30, 2025, and Nov. 10, 2025